Conclusion: SGLT1 can be used as a marker for the diagnosis of DCM, and SGLT1 inhibition can attenuate apoptosis, thereby suppressing DCM development via the JNK and p38 pathway. This evidence concerns the gene MAPK14 and familial dilated cardiomyopathy.